Neil Averitt commentary: Insulin cases need a sharper focus
Washington, D.C. (September 19, 2023) -- Hard cases are notorious for making bad law. But sometimes the easy and obvious cases can make bad law, too. Something like this seems to be going on with insulin pricing....